Research: Aluminum from Vaccines Enters the Brain

Aluminum Poisoning Dangers

Vaccine Aluminum Travels Into The Brain

FEB 10, 2015

…the existing evidence on the toxicology and pharmacokinetics of Al adjuvants…altogether strongly implicate these compounds as contributors to the rising prevalence of neurobehavioural disorders in children.
-Dr Chris Shaw, Neuroscientist and aluminum researcher at University of British Columbia, 2013.

Click for list of papers in this post.

The present article is concerned with the unique way that aluminum adjuvant nanoparticles (AANs) are transported around the body. The movement (“kinetics”) of injected AANs is very different from the movement of ingested aluminum.

The problem is that AANs are not digested by the MF enzymes. Consequently, the AANs remain inside the MFs for a long time. The AANs can persist for years. MFs that consume the AANs become highly contaminated with aluminum, and spread the aluminum wherever they go. And they go everywhere in the body.

The MFs travel across the blood brain barrier (BBB) when there is inflammation in the brain. The MFs, once loaded with AANs, act like a Trojan Horse and carry the AANs into the brain. This is harmful, because the brain is very sensitive to aluminum.

A Pinch Is All It Takes
The brain is extremely sensitive to aluminum. Concentrations of aluminum as low as 10-100 nano-molar can cause inflammation of brain tissue. 10 nano-molar is 270 nano-grams aluminum per liter. (nano = 1 billionth). Thats an amazingly low concentration.

10 nano-molar Al causes inflammation in human blood vessel cells (Alexandrov et al): Nanomolar aluminum induces expression of the inflammatory systemic biomarker C-reactive protein

100 nano-molar Al causes inflammation in human neurons (Lukiw et al):Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture

A typical 1-year old infant has a brain weight of about 1000 grams. A 10 nano-molar concentration in 1000 grams contains 270 nano-grams (0.27 micrograms) of aluminum; a 100 nanomolar concentration in 1000 grams contains 2700 nano-grams (2.7 micrograms). This is extraordinary, because a single vaccine can contain 250 micrograms (250,000 nano-grams), and an infant can receive about 3,675 micrograms in the first 6 months. In other words, less than 0.01% of the aluminum in the first 6 months of vaccines can create a 10-nanomolar concentration in the brain, and 0.1% can create a 100-nanomolar concentration in the brain  (since 3,675 x 0.01% = 0.3675 micrograms, and 3,675 x 0.1% = 3.675 micrograms)). A single vaccine contains more than enough aluminum to inflame the brain.

Of course, this assumes uniform distribution of the aluminum in the brain, which is not the reality. Al concentration in the brain is highly nonuniform. However, the above calculation establishes plausibility. The amount of aluminum in vaccines greatly exceeds the amount necessary to cause brain inflammation.

The Scientific Evidence
The scientific evidence for this “Trojan Horse” mechanism is unequivocal and overwhelming. Every step has been proven by multiple studies from well-known universities and government-funded laboratories: the ingestion of AANs by MFs, the movement of MFs into the brain, and the observation that MFs carry nanoparticles into the brain. Also, the entire process has been demonstrated. AANs injected into experimental animals have been detected and imaged in the brain. The ability of MFs to transport particles into the brain has even been used to deliver therapeutic drugs (formulated as particles) into the brain. The Trojan Horse mechanism is well etablished and recognized. It is not theoretical.

Read More:

Does the Aluminum and Mercury in Vaccines Cross the Blood-Brain Barrier / Create Neurotoxicity?


Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity

GuillemetteCrépeauxab2HousamEidiacMarie-OdileDavidcYasmineBaba-AmeraEleniTzavaradBrunoGirosdFrançois-JérômeAuthieraChristopherExleyeChristopher A.ShawfJosetteCadusseauag1Romain K.Gherardia1

October 2016

We conclude that Alhydrogel® injected at low dose in mouse muscle may selectively induce long-term Al cerebral accumulation and neurotoxic effects. To explain this unexpected result, an avenue that could be explored in the future relates to the adjuvant size since the injected suspensions corresponding to the lowest dose, but not to the highest doses, exclusively contained small agglomerates in the bacteria-size range known to favour capture and, presumably, transportation by monocyte-lineage cells. In any event, the view that Alhydrogel® neurotoxicity obeys “the dose makes the poison” rule of classical chemical toxicity appears overly simplistic.

Read More:

Exposure to Mercury during the First Six Months via Human Milk and Vaccines: Modifying Risk Factors

José G. Dórea
Both of these mechanisms for ensuring good health in children may be compromised by contact with mercury (Hg). Maternal exposure to environmental Hg during pregnancy can predispose nursing children to neurodevelopmental disorders. Despite the World Health Organization assurance that thimerosal-preserved vaccines are safe to use in infants, the United States, the European Union, and dozens of other countries have eliminated thimerosal as a vaccine preservative and stopped the immunization of children with such vaccines. Because of the increase in environmental pollution and the need to produce cheap and safe vaccines, there is a need to address the uncertainty of vaccine-ethylmercury risk of toxicity and Hg exposure during breastfeeding.

Read More:

Injecting Aluminum: Still Not a Good Idea

Aluminum Poisoning Dangers



Suzanne Humphries, a once sought-after nephrologist based out of Maine, has dedicated the last decade of her career to searching for the truth about vaccine safety.

Her most recent book, Dissolving Illusions: Disease, Vaccines and the Forgotten Historyis a telling and thorough collection of historical documents and research that paints a different picture of vaccine safety and efficacy than is commonly presented by pro-vaccine advocates.

In a recent lecture, Humphries explains how aluminum, a widely used vaccine adjuvant, poses a greater risk to the health of the public than once previously thought, especially in regards to vaccines being given to pregnant women.

“Even if vaccines can prevent some infections, considering what’s in them, there’s no way they can improve overall health,” Dr. Humphries says. “And now they want to give vaccines to pregnant women, which in addition to these animal cells and associated genetic material also have aluminum in them.”